Jeong-Gyu Lee
Oprichter bij BRIDGE BIOTHERAPEUTICS, INC.
Vermogen: 4 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Jeong-Gyu Lee
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jeong-Gyu Lee via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin Masters Business Admin | |
| LIPELLA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
| YUANTA SECURITIES KOREA CO., LTD. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Emory University | College/University | Undergraduate Degree | |
| SK GAS CO., LTD. | Gas Distributors | Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
| University of Illinois | College/University | Doctorate Degree | |
| University of Michigan | College/University | Graduate Degree | |
| Yonsei University | College/University | Undergraduate Degree | |
| Seoul National University | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| University of Texas Health Center | College/University | Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
KTB Network Co., Ltd. (Venture Capital)
 KTB Network Co., Ltd. (Venture Capital) Investment ManagersFinance KTB Network Co., Ltd. (Venture Capital) is a venture capital subsidiary of Daol Investment Co., Ltd. founded in 1981. KTB Network Co., Ltd. (Venture Capital) is headquartered in Seongnam, South Korea with offices in Shanghai, Palo Alto and Singapore. | Investment Managers | Private Equity Investor | |
KB Investment Co., Ltd.
 KB Investment Co., Ltd. Investment ManagersFinance KB Investment Co., Ltd. is a private equity/venture capital subsidiary of KB Financial Group, Inc. founded in 1990. The firm is headquartered in Seoul, South Korea. | Investment Managers | Private Equity Investor | |
BioProtect Ltd.
 BioProtect Ltd. Medical SpecialtiesHealth Technology BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel. | Medical Specialties | Director/Board Member | |
| Kyungsung University | College/University | Undergraduate Degree | |
JB Investment Co., Ltd.
 JB Investment Co., Ltd. Investment ManagersFinance JB Investment Co., Ltd. (JB Investment) is a venture capital subsidiary of JB Financial Group Co., Ltd. Founded in 2012. The firm is headquartered in Seoul, South Korea. | Investment Managers | Private Equity Analyst | |
DADAM Investment Corp.
 DADAM Investment Corp. Investment ManagersFinance Dadam Investment Co Ltd (Dadam) is a venture capital firm headquartered in Seoul, Korea. The firm is established in 2013 by Hyeon-Woo Kim. | Investment Managers | Chief Executive Officer | |
GenEdit, Inc.
 GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Director/Board Member | |
RM Global Partners Ltd.
 RM Global Partners Ltd. Investment ManagersFinance RM Global Partners Ltd (RMGLOBAL) is a venture capital subsidiary of RM Global Partners LLC founded in 2012 by Bruce E. Roberts. The firm is headquartered in Hertzliya, Israel. | Investment Managers | Private Equity Investor | |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| The Institute for Money, Technology & Financial Inclusion | College/University | Undergraduate Degree | |
Novatio Ventures
 Novatio Ventures Investment ManagersFinance Novatio Ventures (Novatio Ventures) is a venture capital firm founded in 2015 by Peng Fu. The firm is headquartered in Toronto, Canada. | Investment Managers | Private Equity Investor | |
The Korea Seoul Life Science Fund
 The Korea Seoul Life Science Fund Financial ConglomeratesFinance The Korea Seoul Life Science Fund provides investment services. | Financial Conglomerates | Founder | |
CytoReason Ltd.
 CytoReason Ltd. Information Technology ServicesTechnology Services CytoReason Ltd. is an Israeli company that aims to link mechanisms across diseases, treatments, and patient groups. The company is based in Tel Aviv-Yafo, Israel. The company provides a platform that connects decisions to the underlying science of drug programs. The company's team includes top immunologists, a chief medical officer, a chief data scientist, a VP of strategic alliances, a chief technology officer, and a head of commercial operations. The company focuses on immune-mediated diseases such as inflammatory bowel disease, atopic dermatitis, rheumatoid arthritis, and asthma, immuno-oncology diseases such as non-small cell lung cancer, renal cell carcinoma, and melanoma, and fibrosis diseases such as non-alcoholic steatohepatitis, systemic sclerosis, and idiopathic pulmonary fibrosis. CytoReason was founded in 2016 by Elina Starosvetsky, Ksenya Kveler, Yuval Kalugny, Renaud Gaujoux, David Harel, and Shai Shen-Orr. David Harel has been the CEO since 2016. | Information Technology Services | Director/Board Member Director/Board Member | |
Cell In Cells Co. Ltd.
 Cell In Cells Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Cell In Cells Co. Ltd. is a biotechnology and South Korean healthcare company. | Miscellaneous Commercial Services | Director/Board Member | |
| CHONG KUN DANG PHARMACEUTICAL CORP. | Pharmaceuticals: Major | Consultant / Advisor |
Statistieken
Internationaal
| Verenigde Staten | 18 |
| Zuid-Korea | 12 |
| Israël | 4 |
| Canada | 2 |
Sectoraal
| Consumer Services | 14 |
| Finance | 10 |
| Health Technology | 7 |
| Commercial Services | 3 |
| Utilities | 2 |
Operationeel
| Director/Board Member | 15 |
| Private Equity Investor | 8 |
| Corporate Officer/Principal | 8 |
| Undergraduate Degree | 6 |
| Doctorate Degree | 5 |
Sterkste connecties
| Insiders | |
|---|---|
| B. Christopher Kim | 10 |
| Byong Kim | 9 |
| Min-Sik Shin | 8 |
| Jiwoong Chun | 6 |
| Seung-Hoon Lee | 4 |
| Seung-Yeob Baek | 3 |
| Kwang-Hee Lee | 3 |
| Ju-Yeol Yoo | 3 |
| Sang-Wook Kang | 2 |
| Sujin Jung | 1 |
- Beurs
- Insiders
- Jeong-Gyu Lee
- Bedrijfsconnecties
